No, I am just saying what I know. I am aware that when he was an analyst he was understandably excited. And then the company, that is 2007, just before the financial crisis, hit a financial challenge just like countless tiny bios at the time. Many went out of business entirely, even with trials and promising drugs still. So, you can pretend to be saying something, without context, but the reality is, you are opening a door that if I were him, I’d make you walk through completely.
The reality of investing in any biotech is that there is almost always a very long development stage and anyone who says differently should be viewed cautiously. Traders react quickly to news that they think will get others to bite on then they dump when the buying dries up. Happens all the time because so many are hoping for the quick score but are not in position to know that they are the mark. Wise investors, not just traders, would have known that subsequent expectations being set by the Swiss news were not credible any more than Les trying to cover for the enrollment discrepancy that left out 17 SOC/placebo patients which NWBO apparently felt needed to be done to help protect the blind and ongoing collection of long term data. Biotech investing 101, believe grudgingly and carefully but when certain hold on to what others want to take away; ). Best wishes.
News 
Market Data 
Discover 
AI
